Anteris Technologies Ltd AVR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$23.10
- Day Range
- A$22.80–23.08
- 52-Week Range
- A$15.58–24.38
- Bid/Ask
- A$22.80 / A$23.20
- Market Cap
- A$441.84 Mil
- Volume/Avg
- 7,785 / 19,349
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 87.31
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Anteris Technologies Ltd is a structural heart company engaged in delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. The group's solutions include Anteris’ DurAVR transcatheter heart valve for younger patients who need a heart valve that will last their lifetime, as well as DurAVR with its biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The company derives key revenue from Australia and the U.S.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 108
- Website
- https://www.anteristech.com
Comparables
Valuation
|
Metric
|
AVR
|
LUNG
|
603301
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 7.54 |
Price/Book Value | 14.33 | 2.44 | 0.98 |
Price/Sales | 87.31 | 4.15 | 1.05 |
Price/Cash Flow | — | — | 4.46 |
Price/Earnings
AVR
LUNG
603301
Financial Strength
|
Metric
|
AVR
|
LUNG
|
603301
|
|---|---|---|---|
Quick Ratio | 2.52 | 5.62 | 1.50 |
Current Ratio | 2.98 | 6.50 | 2.21 |
Interest Coverage | — | −19.37 | 24.52 |
Quick Ratio
AVR
LUNG
603301
Profitability
|
Metric
|
AVR
|
LUNG
|
603301
|
|---|---|---|---|
Return on Assets (Normalized) | — | −22.61% | 6.78% |
Return on Equity (Normalized) | — | −31.80% | 9.61% |
Return on Invested Capital (Normalized) | — | −25.75% | 8.71% |
Return on Assets
AVR
LUNG
603301
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Qywfhjm | Lqpyp | $185.8 Bil | |
SYK
| Stryker Corp | Wycgqxssy | Hjf | $127.4 Bil | |
MDT
| Medtronic PLC | Qzpbjpk | Vvwyw | $105.2 Bil | |
BSX
| Boston Scientific Corp | Tglvgfh | Zmrvkr | $99.0 Bil | |
DXCM
| DexCom Inc | Wytmwrlzb | Rkxs | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Jtrmqpsxw | Vskqvh | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Ycpngwznx | Vvph | $25.0 Bil | |
ALGN
| Align Technology Inc | Rvmhydx | Rryhvp | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Nvzkmscp | Bwtjvcz | $18.9 Bil | |
PODD
| Insulet Corp | Vdlcbbsg | Pxqxwr | $11.7 Bil |